|
FIC20230014I1
(en)
|
|
Foslevodopa and foscarbidopa
|
|
KR20180084817A
(en)
|
|
Anti-SIGLEC-9 antibodies and methods of using the same
|
|
DK3653221T3
(en)
|
|
ANTI-PVRIG ANTIBODIES AND METHODS OF USE
|
|
DK3099172T3
(en)
|
|
MODIFIED BIOLOGICAL PERFORMANCE AND ITS USES
|
|
DK3237418T3
(en)
|
|
Triazolopyrimidine Compounds and uses thereof
|
|
DK3142637T3
(en)
|
|
KERATIN TREATMENT FORMULATIONS AND METHODS
|
|
BR112018000129A2
(en)
|
|
oxyesterols and their methods of use
|
|
DK3215147T3
(en)
|
|
NEUROTENANT NORKETAMINE COMPOUNDS AND METHODS
|
|
BR112016023105A2
(en)
|
|
process and method scheduling
|
|
MA40933A
(en)
|
|
DIFLUOROMETHYL-AMINOPYRIDINES AND DIFLUOROMETHYL-AMINOPYRIMIDINES
|
|
DK3319612T3
(en)
|
|
OXYSTEROLS AND METHODS FOR USE THEREOF
|
|
DK3285782T3
(en)
|
|
Tissue repair and regeneration methods
|
|
GB201608459D0
(en)
|
|
Diagnostic methods and kits
|
|
DK3368655T3
(en)
|
|
IMPROVED PROTEIN EXPRESSION AND METHODS THEREOF
|
|
DK3231444T3
(en)
|
|
New treatment
|
|
BR112016022976A2
(en)
|
|
METHODS FOR THE TREATMENT OF HCV
|
|
DK3265641T3
(en)
|
|
RISK AND PROCEDURE
|
|
BR112017000358A2
(en)
|
|
incorporation of biological agents in fertilizers
|
|
CL2016001921A1
(en)
|
|
Immobilized proteins and their use
|
|
DK3390325T3
(en)
|
|
FERTILIZER INCLUDING BACTERIA AND PROTOZOS
|
|
DK3242947T3
(en)
|
|
GENTERAPY AND ELECTROPORESIS FOR THE TREATMENT OF MALIGNITIES
|
|
KR20180084959A
(en)
|
|
Devices and methods for wavefront analysis
|
|
BR112018000204A2
(en)
|
|
colitis treatment methods
|
|
KR20180084747A
(en)
|
|
GALGT2 gene therapy methods and materials
|
|
BR112017007790A2
(en)
|
|
horticultural method and apparatus
|